Defence Therapeutics OTC Stock Top Insiders

Defence Therapeutics Management Team Effectiveness

The company has return on total asset (ROA) of (1.7905) % which means that it has lost $1.7905 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (4.1532) %, meaning that it generated substantial loss on money invested by shareholders. Defence Therapeutics' management efficiency ratios could be used to measure how well Defence Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities.

Defence Therapeutics Workforce Comparison

Defence Therapeutics Benchmark Summation

Defence Therapeutics Notable Stakeholders

The success or failure of an entity such as Defence Therapeutics often depends on how effective the management is. Defence Therapeutics management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Defence management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Defence management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

The data published in Defence Therapeutics' official financial statements typically reflect Defence Therapeutics' business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Defence Therapeutics' quantitative information. For example, before you start analyzing numbers published by Defence accountants, it's essential to understand Defence Therapeutics' liquidity, profitability, and earnings quality within the context of the Healthcare space in which it operates.

When running Defence Therapeutics' price analysis, check to measure Defence Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Defence Therapeutics is operating at the current time. Most of Defence Therapeutics' value examination focuses on studying past and present price action to predict the probability of Defence Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Defence Therapeutics' price. Additionally, you may evaluate how the addition of Defence Therapeutics to your portfolios can decrease your overall portfolio volatility.